Comprehensive Diagnostic & Therapeutic Reference Profile
Also known as: BED, Compulsive Overeating Disorder, Binge Eating Syndrome
Binge Eating Disorder (BED) is a severe, life-threatening, and treatable eating disorder characterized by recurrent episodes of eating large quantities of food (often rapidly and to the point of discomfort) accompanied by a feeling of loss of control during the binge. Unlike bulimia nervosa, binge eating episodes are not followed by compensatory behaviors such as purging, fasting, or excessive exercise.
BED arises from a complex interplay of genetic, biological, and psychosocial factors. It is linked to dysregulation in the hypothalamic-pituitary-adrenal (HPA) axis, abnormal serotonergic and dopaminergic signaling in the brain's reward circuitry, and genetic predisposition involving genes regulating appetite and satiety.
Pathophysiology involves dysfunction in the prefrontal cortex (executive control) and the striatum (reward processing). Patients often experience "hedonic hunger," where the reward system overpowers inhibitory signals, leading to overconsumption. Leptin resistance and altered ghrelin secretion may also disrupt appetite homeostasis.
BED is the most common eating disorder in the United States, with a lifetime prevalence of approximately 1.5–3.5%. It affects all genders, though it is slightly more prevalent in females. Onset typically occurs in late adolescence or early adulthood.
A. Early Symptoms
Vitals often show hypertension. Physical examination may reveal signs of metabolic syndrome, including elevated BMI, acanthosis nigricans, and abdominal distension.
A. Clinical Assessment: DSM-5 criteria fulfillment.
B. Laboratory Testing: Metabolic panels, lipid profile.
C. Imaging Studies: Generally not required unless assessing complications.
D. Functional Tests: Not applicable.
E. Biopsy Findings: None.
F. Genetic Testing: Not clinically indicated.
G. Differential Diagnosis: Bulimia nervosa, Prader-Willi syndrome, night eating syndrome.
Fasting Blood Glucose
Type: Blood Test
Purpose: Screen for metabolic complications (Diabetes)
Expected Findings: Elevated
Interpretation: Indicates metabolic syndrome risk
Abdominal Ultrasound: Used to screen for non-alcoholic fatty liver disease (NAFLD) associated with metabolic shifts in BED patients.
Type 2 diabetes, cardiovascular disease, hypertension, fatty liver disease, joint pain, sleep apnea.
A. Lifestyle Modifications: Nutritional counseling, mindful eating.
B. Preventive Measures: Early intervention in childhood.
C. Medical Treatment: - Stimulants (e.g., Lisdexamfetamine)
Prognosis is generally favorable with multidisciplinary intervention. Remission rates are higher when treated early.
Public awareness, destigmatizing obesity, early screening in primary care.
The following homeopathic remedies have been historically indicated for symptoms associated with Binge Eating Disorder. Selection should be based on individualized symptom totality and constitutional assessment.
This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Binge Eating Disorder.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, identify reference range variances, and generate a plain-English explanation of your disease risks.
Browse our full library of 200+ medical and pathology calculators.
📊 Browse All CalculatorsSpeak with our specialists for a customized treatment protocol for this condition.
📅 Request ConsultationThis clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.